Skip to main content
Industry News
Independence Blue Cross now covers Interpace's thyroid tests

Independence Blue Cross has agreed to cover Interpace Diagnostics' ThyGeNext and ThyraMir molecular thyroid tests, which help assess if initial indeterminate thyroid nodules biopsies are benign or cancerous. The decision makes the tests available to around 2.5 million patients in Southeastern Pennsylvania and Philadelphia.

Full Story: